###begin article-title 0
Notch-induced T cell development requires phosphoinositide-dependent kinase 1
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission.
###end p 1
###begin p 2
###xml 533 534 533 534 <sc>L</sc>
Phosphoinositide-dependent kinase l (PDK1) phosphorylates and activates multiple AGC serine kinases, including protein kinase B (PKB), p70Ribosomal S6 kinase (S6K) and p90Ribosomal S6 kinase (RSK). PDK1 is required for thymocyte differentiation and proliferation, and herein, we explore the molecular basis for these essential functions of PDK1 in T lymphocyte development. A key finding is that PDK1 is required for the expression of key nutrient receptors in T cell progenitors: CD71 the transferrin receptor and CD98 a subunit of L-amino acid transporters. PDK1 is also essential for Notch-mediated trophic and proliferative responses in thymocytes. A PDK1 mutant PDK1 L155E, which supports activation of PKB but no other AGC kinases, can restore CD71 and CD98 expression in pre-T cells and restore thymocyte differentiation. However, PDK1 L155E is insufficient for thymocyte proliferation. The role of PDK1 in thymus development thus extends beyond its ability to regulate PKB. In addition, PDK1 phosphorylation of AGC kinases such as S6K and RSK is also necessary for thymocyte development.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 546 551 546 551 <italic>et al</italic>
###xml 539 557 539 557 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 895 900 895 900 <italic>et al</italic>
###xml 888 906 888 906 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
T cell development in the thymus produces peripheral T cells with a useful repertoire of T cell antigen receptors (TCRs) and is coordinated by extracellular signals from antigen receptors, cytokines and stromal cells. These stimuli link via tyrosine kinases to a diverse network of GTPases and serine kinases. The importance of serine kinases for thymocyte development is revealed by studies of phosphoinositide-dependent kinase l (PDK1), a kinase that phosphorylates a key 'T' loop site within the catalytic domain of AGC serine kinases (Hinton et al, 2004). PDK1 phosphorylates and activates multiple AGC kinases, including phosphatidyl inositol-3 kinase (PI3K)-controlled serine kinases such as Akt or protein kinase B (PKB), the 70-kDa ribosomal S6 kinase-1 (S6K1) and the 90-kDa ribosomal S6 kinase (RSK). Deletion of PDK1 in T cell progenitors causes a block in T cell development (Hinton et al, 2004). PDK1-deficient thymocytes fail to differentiate past the pre-T cell stage and do not make peripheral T cells.
###end p 4
###begin p 5
###xml 220 225 210 215 <italic>et al</italic>
###xml 208 231 198 221 <xref ref-type="bibr" rid="b51">von Boehmer <italic>et al</italic>, 1999</xref>
###xml 233 265 223 255 <xref ref-type="bibr" rid="b31">Michie and Zuniga-Pflucker, 2002</xref>
###xml 773 778 750 755 <italic>et al</italic>
###xml 766 784 743 761 <xref ref-type="bibr" rid="b52">Wolfer <italic>et al</italic>, 2002</xref>
###xml 795 800 772 777 <italic>et al</italic>
###xml 786 806 763 783 <xref ref-type="bibr" rid="b27">Maillard <italic>et al</italic>, 2003</xref>
###xml 816 821 793 798 <italic>et al</italic>
###xml 808 827 785 804 <xref ref-type="bibr" rid="b8">Ciofani <italic>et al</italic>, 2004</xref>
###xml 837 842 814 819 <italic>et al</italic>
###xml 829 849 806 826 <xref ref-type="bibr" rid="b44">Schmitt <italic>et al</italic>, 2004a</xref>
###xml 860 865 837 842 <italic>et al</italic>
###xml 851 871 828 848 <xref ref-type="bibr" rid="b48">Tanigaki <italic>et al</italic>, 2004</xref>
###xml 873 906 850 883 <xref ref-type="bibr" rid="b7">Ciofani and Zuniga-Pflucker, 2005</xref>
###xml 913 918 890 895 <italic>et al</italic>
###xml 908 924 885 901 <xref ref-type="bibr" rid="b24">Laky <italic>et al</italic>, 2006</xref>
The TCR has variable alpha/beta subunits that recognise peptide/MHC complexes and the selection of cells that have successfully rearranged their TCRbeta gene locus is an essential step in T cell development (von Boehmer et al, 1999; Michie and Zuniga-Pflucker, 2002). This occurs in T cell precursors, which do not express the major histocompatibility complex (MHC) receptors CD4 and CD8 (double-negative (DN) thymocytes). T cell progenitors initiate rearrangements of the TCRbeta locus and if successful produce a TCRbeta chain that permits surface expression of the pre-TCR complex comprising TCRbeta, pre-Talpha and CD3 antigens. The pre-TCR, in combination with Notch, then induces proliferation and differentiation into CD4/CD8 double-positive (DP) thymocytes (Wolfer et al, 2002; Maillard et al, 2003; Ciofani et al, 2004; Schmitt et al, 2004a; Tanigaki et al, 2004; Ciofani and Zuniga-Pflucker, 2005; Laky et al, 2006). The process is referred to as beta-selection, because only cells that have successfully rearranged their TCRbeta locus undergo proliferative expansion and differentiate to DPs.
###end p 5
###begin p 6
###xml 53 58 53 58 <italic>et al</italic>
###xml 46 64 46 64 <xref ref-type="bibr" rid="b18">Hinton <italic>et al</italic>, 2006</xref>
###xml 70 75 70 75 <italic>et al</italic>
###xml 66 81 66 81 <xref ref-type="bibr" rid="b29">Mao <italic>et al</italic>, 2007</xref>
###xml 270 275 267 272 <italic>et al</italic>
###xml 263 281 260 278 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 391 396 385 390 <italic>et al</italic>
###xml 384 402 378 396 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 482 515 473 506 <xref ref-type="bibr" rid="b7">Ciofani and Zuniga-Pflucker, 2005</xref>
###xml 713 716 704 707 <italic>Cre</italic>
###xml 798 803 789 794 <italic>et al</italic>
###xml 791 809 782 800 <xref ref-type="bibr" rid="b52">Wolfer <italic>et al</italic>, 2002</xref>
###xml 886 919 877 910 <xref ref-type="bibr" rid="b7">Ciofani and Zuniga-Pflucker, 2005</xref>
###xml 1063 1096 1051 1084 <xref ref-type="bibr" rid="b7">Ciofani and Zuniga-Pflucker, 2005</xref>
###xml 1279 1284 1264 1269 <italic>et al</italic>
###xml 1275 1290 1260 1275 <xref ref-type="bibr" rid="b29">Mao <italic>et al</italic>, 2007</xref>
The pre-TCR activates PDK1-regulated kinases (Hinton et al, 2006; Mao et al, 2007) and these are clearly essential for thymocyte development as PDK1-null pre-T cells do not proliferate or differentiate yet express TCRbeta subunits and have a functioning pre-TCR (Hinton et al, 2004). Loss of PDK1 causes a size reduction of beta-selected pre-T cells indicative of a metabolic defect (Hinton et al, 2004). In this context, Notch signals support metabolism throughout beta-selection (Ciofani and Zuniga-Pflucker, 2005) and the failed development of PDK1-null cells could thus reflect defective trophic responses to Notch. A number of facts are consistent with this hypothesis: deletion of floxed Notch1 alleles via Cre excision blocks thymocyte development at the same stage as PDK1 deletion (Wolfer et al, 2002); Notch-ligand interactions in pre-T cells activate the PDK1 substrate PKB (Ciofani and Zuniga-Pflucker, 2005); expression of a constitutively active PKB mutant can partially substitute for Notch and maintain thymocyte metabolism during beta-selection (Ciofani and Zuniga-Pflucker, 2005); and PKB serine kinases are required for the transition of DN thymocytes to the DP stage, partly by enhancing the proliferation and survival of cells undergoing beta-selection (Mao et al, 2007). A key question then is whether the impact of PDK1 loss on thymocyte development stems only from its key role in regulating PKB and/or reflects the unresponsiveness of cells to Notch-induced trophic signals.
###end p 6
###begin p 7
###xml 125 133 125 133 <italic>in vitro</italic>
###xml 269 274 269 274 <italic>et al</italic>
###xml 261 281 261 281 <xref ref-type="bibr" rid="b45">Schmitt <italic>et al</italic>, 2004b</xref>
###xml 283 316 283 316 <xref ref-type="bibr" rid="b43">Schmitt and Zuniga-Pflucker, 2006</xref>
###xml 609 614 609 614 <italic>et al</italic>
###xml 601 620 601 620 <xref ref-type="bibr" rid="b9">Collins <italic>et al</italic>, 2003</xref>
###xml 622 626 622 626 <xref ref-type="bibr" rid="b10">2005</xref>
###xml 949 954 949 954 <italic>et al</italic>
###xml 942 960 942 960 <xref ref-type="bibr" rid="b3">Biondi <italic>et al</italic>, 2000</xref>
###xml 962 966 962 966 <xref ref-type="bibr" rid="b4">2001</xref>
###xml 975 980 975 980 <italic>et al</italic>
###xml 968 986 968 986 <xref ref-type="bibr" rid="b14">Frodin <italic>et al</italic>, 2000</xref>
###xml 988 992 988 992 <xref ref-type="bibr" rid="b13">2002</xref>
###xml 1099 1104 1099 1104 <italic>et al</italic>
###xml 1091 1110 1091 1110 <xref ref-type="bibr" rid="b9">Collins <italic>et al</italic>, 2003</xref>
###xml 1219 1226 1219 1226 <italic>in vivo</italic>
###xml 1236 1241 1236 1241 <italic>et al</italic>
###xml 1228 1247 1228 1247 <xref ref-type="bibr" rid="b9">Collins <italic>et al</italic>, 2003</xref>
###xml 1258 1263 1258 1263 <italic>et al</italic>
###xml 1249 1269 1249 1269 <xref ref-type="bibr" rid="b1">Bayascas <italic>et al</italic>, 2006</xref>
###xml 1422 1427 1422 1427 <italic>et al</italic>
###xml 1413 1433 1413 1433 <xref ref-type="bibr" rid="b1">Bayascas <italic>et al</italic>, 2006</xref>
###xml 1596 1601 1596 1601 <italic>et al</italic>
###xml 1588 1607 1588 1607 <xref ref-type="bibr" rid="b30">McManus <italic>et al</italic>, 2004</xref>
###xml 1480 1486 <span type="species:ncbi:10090">murine</span>
To address these issues, the present study compares the development of wild-type (WT) and PDK1-null T cell progenitors in an in vitro model that uses OP9 stromal cells expressing the Notch ligand delta-like 1 (OP9-DL1 cells) to drive thymocyte differentiation (Schmitt et al, 2004b; Schmitt and Zuniga-Pflucker, 2006). To determine the contribution of the PDK1/PKB pathway to thymocyte development, we studied the differentiation of thymocytes whose WT PDK1 allele were substituted with a PDK1 L155E mutant, that permits phosphorylation of PKB, but not other substrates such as S6K1, PKC, SGK or RSK (Collins et al, 2003, 2005). The substitution of leucine (L) 155 in PDK1 with glutamate (E) disrupts the integrity of an important PDK1 domain termed the PIF-binding pocket. This domain is not required for PKB phosphorylation, but is necessary for PDK1 to interact with carboxy-terminal hydrophobic motifs in substrates such as S6K1 and RSK (Biondi et al, 2000, 2001; Frodin et al, 2000, 2002). The PDK1 L155E mutant can thus support normal activation of PKB, but not S6K1 and RSK activity (Collins et al, 2003). The value of PDK1 L155E in dissecting the contribution of different PDK1 substrates has been demonstrated in vivo (Collins et al, 2003; Bayascas et al, 2006). It can substitute for WT PDK1 in insulin responses in skeletal muscle demonstrating that PKB is the relevant target for PDK1 in these cells (Bayascas et al, 2006). However, PDK1 L155E does not support normal murine embryo development, indicating that PDK1 activation of PKB is not sufficient for all PDK1 functions (McManus et al, 2004).
###end p 7
###begin p 8
The present results show that PDK1-null pre-T cells cannot respond to Notch-induced trophic signals, because Notch signals via PDK1 to induce and sustain expression of key nutrient receptors. In the absence of PDK1, pre-T cells are blocked at the DN stage of thymocyte differentiation. Expression of PDK1 L155E, which supports activation of PKB is able to replace WT PDK1 and restore nutrient receptor expression and pre-T cell differentiation, but does not restore normal thymus cellularity. These results identify an important role for the PDK1/PKB pathway during thymocyte differentiation, but show that the importance of PDK1 in the thymus cannot be ascribed solely to its role upstream of PKB. T cell development is thus equally dependent on PDK1 substrates that interact with PDK1 via its PIF domain.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
PDK1-deficient pre-T cells cannot respond to Notch signals and have defective expression of key nutrient receptors
###end title 10
###begin p 11
###xml 173 181 173 181 <italic>in vitro</italic>
###xml 316 324 316 324 <italic>in vitro</italic>
###xml 326 359 326 359 <xref ref-type="bibr" rid="b41">Schmitt and Zuniga-Pflucker, 2002</xref>
###xml 361 382 361 382 <xref ref-type="bibr" rid="b53">Zuniga-Pflucker, 2004</xref>
###xml 430 451 430 443 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 451 458 443 450 <italic>Lck-Cre</italic>
###xml 458 459 450 451 <sup>+</sup>
###xml 497 500 489 492 <sup>&#8722;/&#8722;</sup>
###xml 598 619 590 603 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 629 634 613 618 <italic>et al</italic>
###xml 622 640 606 624 <xref ref-type="bibr" rid="b25">Lawlor <italic>et al</italic>, 2002</xref>
###xml 663 666 647 650 <italic>Cre</italic>
###xml 716 719 700 703 <italic>lck</italic>
###xml 716 719 700 703 <sup><italic>lck</italic></sup>
###xml 739 746 723 730 <italic>Lck-Cre</italic>
###xml 746 747 730 731 <sup>+</sup>
###xml 764 767 748 751 <italic>Cre</italic>
###xml 828 833 812 817 <italic>et al</italic>
###xml 819 839 803 823 <xref ref-type="bibr" rid="b47">Takahama <italic>et al</italic>, 1998</xref>
###xml 848 853 832 837 <italic>et al</italic>
###xml 841 859 825 843 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 997 998 981 982 <sup>+</sup>
###xml 1003 1004 987 988 <sup>&#8722;</sup>
###xml 1040 1041 1024 1025 <sup>+</sup>
###xml 1046 1047 1030 1031 <sup>+</sup>
###xml 1059 1060 1043 1044 <sup>&#8722;</sup>
###xml 1065 1066 1049 1050 <sup>+</sup>
###xml 1081 1082 1065 1066 <sup>&#8722;</sup>
###xml 1087 1088 1071 1072 <sup>&#8722;</sup>
###xml 1117 1120 1101 1104 <sup>&#8722;/&#8722;</sup>
###xml 1185 1190 1169 1174 <italic>et al</italic>
###xml 1178 1196 1162 1180 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
To assess whether PDK1 is required for Notch-induced thymocyte growth, differentiation and proliferation, we compared the responses of WT versus PDK1-null pre-T cells in an in vitro system using OP9 stromal cells expressing the OP9-DL1. The OP9-DL1 system allows an assessment of Notch responsiveness in pre-T cells in vitro (Schmitt and Zuniga-Pflucker, 2002; Zuniga-Pflucker, 2004). PDK1-null pre-T cells were obtained from PDK1flDeltaneo/flDeltaneoLck-Cre+ mice (hereafter referred to as T-PDK1-/- mice), which were generated by crossing mice with floxed PDK1 exons 3 and 4 on both alleles (PDK1flDeltaneo/flDeltaneo) (Lawlor et al, 2002) with mice expressing Cre recombinase under the control of the proximal p56lck proximal promoter (Lck-Cre+), which induces Cre expression in DN T cell progenitors in the thymus (Takahama et al, 1998; Hinton et al, 2004). DN thymocytes can be subdivided on the basis of differential surface expression of CD44 and CD25: the first T cell progenitors are CD44+/CD25- (DN1) followed sequentially by CD44+/CD25+ (DN2), CD44-/CD25+ (DN3) and CD44-/CD25- (DN4) populations. In T-PDK1-/-, thymocytes are blocked in development at the DN4 stage (Hinton et al, 2004).
###end p 11
###begin p 12
###xml 123 132 123 132 <xref ref-type="fig" rid="f1">Figure 1A</xref>
###xml 273 282 273 282 <xref ref-type="fig" rid="f1">Figure 1B</xref>
###xml 421 430 421 430 <xref ref-type="fig" rid="f1">Figure 1B</xref>
###xml 439 442 439 442 <sup>&#8722;/&#8722;</sup>
###xml 511 520 511 520 <xref ref-type="fig" rid="f1">Figure 1C</xref>
###xml 570 579 570 579 <xref ref-type="fig" rid="f1">Figure 1D</xref>
###xml 606 609 606 609 <sup>&#8722;/&#8722;</sup>
###xml 651 660 651 660 <xref ref-type="fig" rid="f1">Figure 1A</xref>
###xml 668 677 668 677 <xref ref-type="fig" rid="f1">Figure 1C</xref>
###xml 705 712 705 712 <italic>ex vivo</italic>
###xml 746 751 746 751 <italic>et al</italic>
###xml 739 757 739 757 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 798 807 798 807 <xref ref-type="fig" rid="f1">Figure 1E</xref>
WT DNs cultured on OP9-DL1 cells increase in cell size, whereas cells cultured on OP9 cells in the absence of DL-1 do not (Figure 1A). DNs cultured on OP9-DL1 cells also proliferate (70- to 80-fold in 6 days) and differentiate to DP thymocytes that co-express CD4 and CD8 (Figure 1B). In contrast, DN thymocytes cultured on OP9 cells in the absence of Notch ligand do not proliferate, although they differentiate to DPs (Figure 1B). T-PDK1-/- DN thymocytes fail to increase in cell size in response to OP9-DL1 (Figure 1C) and do not proliferate or differentiate to DPs (Figure 1D). The small size of T-PDK1-/- DN thymocytes cultured on OP9-DL1 cells (Figure 1A versus Figure 1C) parallels what is seen in ex vivo PDK1 deleted pre-T cells (Hinton et al, 2004), which are small compared to controls (Figure 1E).
###end p 12
###begin p 13
###xml 185 188 185 188 <sup>&#8722;/&#8722;</sup>
###xml 269 274 269 274 <italic>et al</italic>
###xml 258 280 258 280 <xref ref-type="bibr" rid="b2">Besseyrias <italic>et al</italic>, 2007</xref>
###xml 283 292 283 292 <xref ref-type="fig" rid="f1">Figure 1F</xref>
###xml 469 472 469 472 <sup>&#8722;/&#8722;</sup>
###xml 654 676 654 676 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
###xml 693 696 693 696 <sup>&#8722;/&#8722;</sup>
###xml 772 781 772 781 <xref ref-type="fig" rid="f1">Figure 1F</xref>
###xml 802 811 802 811 <xref ref-type="fig" rid="f1">Figure 1G</xref>
PDK1-null pre-T cells thus do not grow, differentiate or proliferate in response to Notch. We examined whether this defect could be attributed to defective expression of Notch on T-PDK1-/- DNs. A DL4-IgG fusion protein was used to monitor Notch1 expression (Besseyrias et al, 2007). Figure 1F shows that WT and PDK1-null pre-T cells express Notch1. There is a two-fold reduction in Notch1 expression in PDK1-null cells, but does not explain failed development of T-PDK1-/- DNs as Notch1 haploinsufficient thymocytes develop normally (F Radtke, personal communication) and within WT DN4s, two-fold differences in Notch1 levels had no impact on cell size (Supplementary Figure 1). Moreover, PDK1-/- DN4s expressing identical levels of surface Notch1 as WT DN4s (Region A in Figure 1F) are still smaller (Figure 1G).
###end p 13
###begin p 14
###xml 148 153 148 153 <italic>et al</italic>
###xml 135 159 135 159 <xref ref-type="bibr" rid="b15">Gottesdiener <italic>et al</italic>, 1988</xref>
###xml 170 175 170 175 <italic>et al</italic>
###xml 161 181 161 181 <xref ref-type="bibr" rid="b26">Lindsten <italic>et al</italic>, 1988</xref>
###xml 192 197 192 197 <italic>et al</italic>
###xml 183 203 183 203 <xref ref-type="bibr" rid="b33">Parmacek <italic>et al</italic>, 1989</xref>
###xml 214 219 214 219 <italic>et al</italic>
###xml 205 225 205 225 <xref ref-type="bibr" rid="b38">Rathmell <italic>et al</italic>, 2000</xref>
###xml 227 253 227 253 <xref ref-type="bibr" rid="b12">Edinger and Thompson, 2002</xref>
###xml 377 382 377 382 <italic>et al</italic>
###xml 367 388 367 388 <xref ref-type="bibr" rid="b46">Schneider <italic>et al</italic>, 1982</xref>
###xml 390 422 390 422 <xref ref-type="bibr" rid="b49">Trowbridge and Shackelford, 1986</xref>
###xml 728 737 728 737 <xref ref-type="fig" rid="f2">Figure 2A</xref>
###xml 1028 1037 1025 1034 <xref ref-type="fig" rid="f2">Figure 2B</xref>
###xml 1286 1295 1283 1292 <xref ref-type="fig" rid="f2">Figure 2B</xref>
###xml 1358 1365 1355 1362 <italic>ex vivo</italic>
###xml 1367 1376 1364 1373 <xref ref-type="fig" rid="f2">Figure 2A</xref>
###xml 1524 1533 1521 1530 <xref ref-type="fig" rid="f2">Figure 2C</xref>
###xml 1814 1823 1811 1820 <xref ref-type="fig" rid="f2">Figure 2C</xref>
T lymphocyte cell size is dependent on the regulated expression of amino-acid transporters that include CD98 (42F) as a key component (Gottesdiener et al, 1988; Lindsten et al, 1988; Parmacek et al, 1989; Rathmell et al, 2000; Edinger and Thompson, 2002). The upregulation of CD71, the transferrin receptor, mediates iron uptake and is also critical for cell growth (Schneider et al, 1982; Trowbridge and Shackelford, 1986). Therefore, we considered whether defective growth response of PDK1-null pre-T cells might result from defective expression of nutrient transporters during thymus development. In initial experiments, we explored whether thymocyte differentiation is accompanied by changes in expression of CD71 and CD98. Figure 2A shows that DN3 thymocytes express low levels of CD98 and CD71, whereas surface expression of these nutrient transporters is high in DN4s. Progression through beta-selection is thus accompanied by upregulation of CD71 and CD98. We then asked whether Notch controls CD71 and CD98 expression. Figure 2B shows that DN3 thymocytes cultured on OP9-DL1 cells upregulate expression of CD71 and CD98, but this does not happen when they are cultured on OP9 cells in the absence of Notch signalling. DN3s cultured on OP9-DL1 cells also increase in cell size (Figure 2B). DN4 thymocytes have high levels of CD71 and CD98 expression ex vivo (Figure 2A); they strikingly lose expression of these receptors if cultured on OP9 cells, but maintain CD71 and CD98 expression if cultured on OP9-DL1 cells (Figure 2C). Hence, sustained Notch signalling is required to maintain CD98 and CD71 surface expression on DN4 thymocytes. The cell size of DN4 thymocytes is also sustained by Notch: DN4s cultured on OP9 cells rapidly decrease in size, but maintain cell size when cultured on OP9-DL1 cells (Figure 2C).
###end p 14
###begin p 15
###xml 310 313 310 313 <sup>&#8722;/&#8722;</sup>
###xml 354 363 354 363 <xref ref-type="fig" rid="f2">Figure 2D</xref>
###xml 379 382 379 382 <sup>&#8722;/&#8722;</sup>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
Notch1 thus regulates nutrient receptor expression on pre-T cells, but a key question is whether pre-TCR signalling is essential for T cells to become competent to respond to Notch1 in the context of CD98 and CD71 expression. To address this issue, we cultured DN3 cells from Recombinase gene 2-null mice (Rag2-/-) that lack a pre-TCR, on OP9-DL1 cells. Figure 2D shows that Rag2-/- DN3s fail to upregulate CD98 and CD71 when cultured on OP9-DL1 cells. Hence, Notch is not sufficient to regulate CD71 and CD98 expression in the absence of the pre-TCR, rather Notch is required to sustain expression of CD98 and CD71 on beta-selected pre-T cells.
###end p 15
###begin p 16
###xml 68 71 68 71 <sup>&#8722;/&#8722;</sup>
###xml 87 90 87 90 <sup>&#8722;/&#8722;</sup>
###xml 240 245 240 245 <italic>et al</italic>
###xml 233 251 233 251 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 254 263 254 263 <xref ref-type="fig" rid="f2">Figure 2E</xref>
###xml 328 331 328 331 <sup>&#8722;/&#8722;</sup>
###xml 374 377 374 377 <sup>&#8722;/&#8722;</sup>
###xml 584 587 584 587 <sup>&#8722;/&#8722;</sup>
###xml 715 718 715 718 <sup>&#8722;/&#8722;</sup>
###xml 819 824 819 824 <italic>et al</italic>
###xml 812 830 812 830 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
Next, we examined CD71 and CD98 expression in thymocytes from T-PDK1-/- mice. In T-PDK1-/- mice, there is partial deletion of PDK1 in DN3s, complete PDK1 loss in the DN4s and a failure of these cells to develop beyond the DN4 stage (Hinton et al, 2004). Figure 2E shows that CD98 and CD71 expression levels are defective in PDK1-/- DN4 thymocytes. DN4 thymocytes from T-PDK1-/- mice were uniformly low for CD98 expression and had a high frequency of CD71 low cells compared to WT controls. The loss of CD71 and CD98 expression is not reflective of a global signalling defect in T-PDK1-/- DN4s, because the upregulation of a number of other surface receptors occurs normally as PDK1-null DN3s transit to DN4s. T-PDK1-/- DN4s can thus upregulate CD2 and CD5 expression normally; a marker of a functioning pre-TCR (Hinton et al, 2004). The reduced expression of CD98 and CD71 on PDK1-null DN4s reveals that the expression of these key nutrient receptors is mediated by PDK1.
###end p 16
###begin p 17
###xml 503 525 503 525 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 2</xref>
Is reduced expression of nutrient receptors sufficient to explain the defective growth responses of pre-T cells? Experiments to limit nutrient availability revealed that the ability of pre-T cells to increase cell size and develop in response to Notch was dependent on the availability of exogenous amino acids (data not shown). We also examined whether differences in levels of expression of nutrient receptors on the surface of pre-T cells had an impact on trophic responses in pre-T cells. The data (Supplementary Figure 2) show that WT DN4s expressing low levels of CD71 or CD98 are small cells compared to cells expressing high levels of CD71. Hence, expression of CD98 and CD71 is rate limiting for pre-T cell growth.
###end p 17
###begin title 18
A PDK1 L155E mutant supports nutrient receptor expression and pre-T cell differentiation
###end title 18
###begin p 19
###xml 217 243 217 243 <xref ref-type="bibr" rid="b12">Edinger and Thompson, 2002</xref>
###xml 547 552 547 552 <italic>et al</italic>
###xml 540 558 540 558 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 564 569 564 569 <italic>et al</italic>
###xml 560 575 560 575 <xref ref-type="bibr" rid="b29">Mao <italic>et al</italic>, 2007</xref>
There are multiple PDK1 substrates in T cells, including PKB, S6K1 and RSK. Expression of constitutively active PKB mutants can substitute for cytokines and induce expression of CD71 and CD98 in haematopoietic cells (Edinger and Thompson, 2002). PDK1 is necessary for PKB activation and hence the impact of PDK1 loss on thymocyte development could reflect loss of PKB activity in these cells. In this context, simultaneous loss of three PKB isoforms blocks thymocyte development at the DN/DP stage, similar to the effects of deleting PDK1 (Hinton et al, 2004; Mao et al, 2007). However, it is not known if PKB is the only effector of PDK1 in the thymus and it is important to address the involvement of additional PDK1 substrates in T cell development.
###end p 19
###begin p 20
###xml 205 210 205 210 <italic>et al</italic>
###xml 199 216 199 216 <xref ref-type="bibr" rid="b22">Jones <italic>et al</italic>, 2000</xref>
###xml 226 231 226 231 <italic>et al</italic>
###xml 218 237 218 237 <xref ref-type="bibr" rid="b34">Parsons <italic>et al</italic>, 2001</xref>
###xml 239 265 239 265 <xref ref-type="bibr" rid="b12">Edinger and Thompson, 2002</xref>
###xml 270 275 270 275 <italic>et al</italic>
###xml 267 281 267 281 <xref ref-type="bibr" rid="b32">Na <italic>et al</italic>, 2003</xref>
###xml 292 297 292 297 <italic>et al</italic>
###xml 283 303 283 303 <xref ref-type="bibr" rid="b37">Rathmell <italic>et al</italic>, 2003</xref>
###xml 311 316 311 316 <italic>et al</italic>
###xml 305 322 305 322 <xref ref-type="bibr" rid="b35">Patra <italic>et al</italic>, 2004</xref>
###xml 533 540 533 540 <italic>in vivo</italic>
###xml 611 616 611 616 <italic>et al</italic>
###xml 603 622 603 622 <xref ref-type="bibr" rid="b9">Collins <italic>et al</italic>, 2003</xref>
###xml 624 628 624 628 <xref ref-type="bibr" rid="b10">2005</xref>
###xml 638 643 638 643 <italic>et al</italic>
###xml 630 649 630 649 <xref ref-type="bibr" rid="b30">McManus <italic>et al</italic>, 2004</xref>
###xml 660 665 660 665 <italic>et al</italic>
###xml 651 671 651 671 <xref ref-type="bibr" rid="b1">Bayascas <italic>et al</italic>, 2006</xref>
###xml 804 809 804 809 <italic>et al</italic>
###xml 796 815 796 815 <xref ref-type="bibr" rid="b9">Collins <italic>et al</italic>, 2003</xref>
###xml 817 826 817 826 <xref ref-type="fig" rid="f3">Figure 3A</xref>
###xml 1019 1026 1019 1026 <sup>L155E/&#8722;</sup>
###xml 1126 1142 1126 1138 <sup>L155E/fl&#916;neo</sup>
###xml 1165 1168 1161 1164 <italic>Cre</italic>
###xml 1209 1212 1205 1208 <sup>lck</sup>
###xml 1232 1254 1228 1250 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 3</xref>
###xml 1404 1407 1400 1403 <italic>Cre</italic>
###xml 1522 1538 1518 1530 <sup>L155E/fl&#916;neo</sup>
###xml 1538 1545 1530 1537 <italic>Lck-Cre</italic>
###xml 1545 1546 1537 1538 <sup>+</sup>
###xml 1568 1575 1560 1567 <sup>L155E/&#8722;</sup>
###xml 1916 1928 1908 1916 <sup>+/fl&#916;neo</sup>
###xml 1928 1935 1916 1923 <italic>Lck-Cre</italic>
###xml 1935 1936 1923 1924 <sup>+</sup>
###xml 1959 1962 1947 1950 <sup>+/&#8722;</sup>
###xml 2236 2241 2224 2229 <italic>et al</italic>
###xml 2230 2247 2218 2235 <xref ref-type="bibr" rid="b23">Kelly <italic>et al</italic>, 2006</xref>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 829 833 <span type="species:ncbi:10090">Mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
###xml 1149 1153 <span type="species:ncbi:10090">mice</span>
###xml 1332 1337 <span type="species:ncbi:10090">mouse</span>
One way to explore the contribution of PKB to PDK1 function is to use ectopically expressed constitutively active PKB mutants, a strategy used to determine much of what we know about PKB in T cells (Jones et al, 2000; Parsons et al, 2001; Edinger and Thompson, 2002; Na et al, 2003; Rathmell et al, 2003; Patra et al, 2004). However, PKB mutants may not necessarily mimic the actions of endogenous PKB. One alternative and powerful strategy to explore the relative contributions of different PDK1 substrates to a biological response in vivo is to analyse mice with 'knock-in' mutations of PDK1 alleles (Collins et al, 2003, 2005; McManus et al, 2004; Bayascas et al, 2006). One such PDK1 mutant, containing a L155E mutation, cannot support activation of S6K and RSK but allows activation of PKB (Collins et al, 2003; Figure 3A). Mice that are homozygous for the PDK1 L155E mutation do not survive beyond developmental stage E12. However, it is possible to generate thymocytes that selectively express PDK1 L155E (T-PDK1L155E/-) by backcrossing mice that express a single PDK1 L155E allele and a single PDK1 floxed allele (PDK1L155E/flDeltaneo) with mice expressing Cre recombinase under the control of the p56lck proximal promoter (Supplementary Figure 3). The presence of the single PDK1 floxed allele in all tissues allows normal mouse development. However, as progenitors enter the thymus and express Cre recombinase, the WT allele is deleted thereby generating pre-T cells that express a single PDK1 L155E allele (PDK1L155E/flDeltaneoLck-Cre+, referred to as T-PDKL155E/-). A comparison of the ability of a single PDK L155E allele versus a single WT allele to support T cell development can then be assessed relative to the impact of complete PDK1 deletion. The crucial control for the analysis of pre-T cells that express the single L155E mutant allele are pre-T cells that express a single WT PDK1 allele (PDK1+/flDeltaneoLck-Cre+, referred to as T-PDK1+/-). The impact of PDK1 haplo-insufficiency on thymocyte development has been described and of relevance to the present work is the fact that a single WT PDK1 allele restores DN4 cell size and cell cycle progression and allows thymocyte differentiation from DNs to DPs (Kelly et al, 2006).
###end p 20
###begin p 21
###xml 212 215 212 215 <sup>+/&#8722;</sup>
###xml 226 233 226 233 <sup>L155E/&#8722;</sup>
###xml 240 249 240 249 <xref ref-type="fig" rid="f3">Figure 3B</xref>
###xml 526 529 526 529 <sup>+/&#8722;</sup>
###xml 540 547 540 547 <sup>L155E/&#8722;</sup>
###xml 569 578 569 578 <xref ref-type="fig" rid="f3">Figure 3C</xref>
###xml 581 590 581 590 <xref ref-type="fig" rid="f3">Figure 3D</xref>
###xml 615 618 615 618 <sup>&#8722;/&#8722;</sup>
###xml 688 695 688 695 <sup>L155E/&#8722;</sup>
###xml 880 887 877 884 <sup>L155E/&#8722;</sup>
###xml 895 904 892 901 <xref ref-type="fig" rid="f3">Figure 3E</xref>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
Experiments with PDK1 L155E explore whether kinases that interact with PDK1 via its PIF domain are required for thymocyte development. Initially, we compared CD71 and CD98 expression in DN4 thymocytes from T-PDK1+/- and T-PDK1L155E/- mice. Figure 3B shows that expression of PDK1 L155E restores CD71 and CD98 expression to a level comparable to that seen in DN4s expressing WT PDK1. PDK1 L155E could also restore thymocyte differentiation in PDK1 null pre-T cells. The distribution of the different DN subpopulations in T-PDK1+/- and T-PDK1L155E/- mice was comparable (Figure 3C). Figure 3D shows that unlike T-PDK1-/- thymi, which have virtually no DPs and single positives (SPs), T-PDK1L155E/- thymi contain DP and SP subsets at relatively normal ratios. Mature WT SP thymocytes express high surface levels of the TCRbeta and there was a normal frequency of these cells in T-PDKL155E/- thymi (Figure 3E). PDK1 L155E can thus substitute for PDK1 loss and is sufficient for normal CD71 and CD98 expression and for pre-T cell differentiation into DPs and SPs.
###end p 21
###begin p 22
###xml 37 40 37 40 <italic>Cre</italic>
###xml 105 112 101 108 <sup>L155E/&#8722;</sup>
###xml 118 140 114 136 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 4</xref>
###xml 255 262 251 258 <sup>L155E/&#8722;</sup>
###xml 578 583 574 579 <italic>et al</italic>
###xml 570 589 566 585 <xref ref-type="bibr" rid="b9">Collins <italic>et al</italic>, 2003</xref>
###xml 878 883 874 879 <italic>et al</italic>
###xml 871 889 867 885 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 892 901 888 897 <xref ref-type="fig" rid="f3">Figure 3F</xref>
###xml 1084 1093 1080 1089 <xref ref-type="fig" rid="f3">Figure 3G</xref>
###xml 1304 1313 1296 1305 <xref ref-type="fig" rid="f3">Figure 3G</xref>
A genomic PCR analysis verified that Cre-mediated deletion of the flDeltaneo allele had occurred in T-PDKL155E/- DPs (Supplementary Figure 4). There was also functional loss of PDK1 as judged by failed phosphorylation of the ribosomal S6 subunit in T-PDK1L155E/-DN4 thymocytes. S6 phosphorylation is mediated by S6K1, which requires phosphorylation at its 'T loop' site by PDK1. A crucial step that enables this phosphorylation event is the docking of PDK1 via its PIF domain at a hydrophobic-motif in S6K. The L155E mutant of PDK1 is thus defective in activating S6K1 (Collins et al, 2003). The activity of S6K1 can be monitored by quantification of phosphorylation of its substrate, the ribosomal S6 subunit, by intracellular staining with specific phosphorylated S6 antisera. Basal levels of S6 phosphorylation are high in WT DN4s, but absent following PDK1 deletion (Hinton et al, 2004). Figure 3F shows that expression of a single WT PDK1 allele can support activation of S6K1 in pre-T cells, but the PDK1 L155E allele cannot. These data were confirmed by western blot analysis (Figure 3G). Western blot data also confirm that PDK1 L155E can support PKB activity as determined by the normal phosphorylation of GSK3alpha on its PKB substrate sequence Serine 21 in both WT and PDK1 L155E pre-T cells (Figure 3G). In contrast, GSK3alpha Serine 21 phosphorylation is absent in PDK1-null pre-T cells.
###end p 22
###begin title 23
PDK1 L155E is not sufficient for cell growth or proliferation of pre-T cells
###end title 23
###begin p 24
###xml 280 287 277 284 <sup>L155E/&#8722;</sup>
###xml 294 303 291 300 <xref ref-type="fig" rid="f4">Figure 4A</xref>
###xml 312 319 309 316 <sup>L155E/&#8722;</sup>
###xml 427 436 417 426 <xref ref-type="fig" rid="f4">Figure 4B</xref>
###xml 594 601 584 591 <sup>L155E/&#8722;</sup>
###xml 703 710 693 700 <sup>L155E/&#8722;</sup>
###xml 717 726 707 716 <xref ref-type="fig" rid="f4">Figure 4C</xref>
###xml 832 839 822 829 <sup>L155E/&#8722;</sup>
###xml 846 855 836 845 <xref ref-type="fig" rid="f4">Figure 4D</xref>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
PDK1 L155E substitutes for WT PDK1 in the context of CD98 and CD71 expression and DN to DP differentiation. However, DN to DP transition is normally accompanied by a large proliferative expansion of beta-selected pre-T cells and there was no such proliferative expansion in T-PDK1L155E/- mice (Figure 4A). T-PDK1L155E/- mice thus have very low numbers of DPs and SPs and peripheral alpha/beta T cells compared to control mice (Figure 4B). PDK1 L155E thus supports DN to DP differentiation, but does not restore thymus cellularity. In accordance with the failed proliferative expansion of T-PDK1L155E/- thymocytes, there was a decrease in the frequency of cells in S/G2 phases of the cell cycle in T-PDK1L155E/- DN4s (Figure 4C). Moreover, the normal increase in cell size that accompanies the DN3 to DN4 transition is lost in T-PDK1L155E/- mice (Figure 4D). Hence, expression of a single WT PDK1 allele can maintain normal growth and proliferation of pre-T cells, whereas PDK1 L155E cannot. Thus, PDK1 activation of PKB is sufficient for pre-T cell differentiation, but PDK1 substrates that interact with PDK1 via its PIF domain are required for optimal pre-T cell growth and proliferative expansion.
###end p 24
###begin title 25
Notch-induced proliferation but not differentiation of T cell progenitors is mTOR and RSK dependent
###end title 25
###begin p 26
###xml 107 112 107 112 <italic>et al</italic>
###xml 99 118 99 118 <xref ref-type="bibr" rid="b9">Collins <italic>et al</italic>, 2003</xref>
###xml 243 248 243 248 <italic>et al</italic>
###xml 235 254 235 254 <xref ref-type="bibr" rid="b39">Sapkota <italic>et al</italic>, 2007</xref>
###xml 347 352 347 352 <italic>et al</italic>
###xml 339 358 339 358 <xref ref-type="bibr" rid="b39">Sapkota <italic>et al</italic>, 2007</xref>
###xml 361 370 361 370 <xref ref-type="fig" rid="f5">Figure 5A</xref>
###xml 553 562 553 562 <xref ref-type="fig" rid="f5">Figure 5B</xref>
###xml 1034 1039 1034 1039 <italic>et al</italic>
###xml 1028 1045 1028 1045 <xref ref-type="bibr" rid="b20">Inoki <italic>et al</italic>, 2002</xref>
###xml 1056 1061 1056 1061 <italic>et al</italic>
###xml 1047 1067 1047 1067 <xref ref-type="bibr" rid="b21">Jaeschke <italic>et al</italic>, 2002</xref>
###xml 1077 1082 1077 1082 <italic>et al</italic>
###xml 1069 1088 1069 1088 <xref ref-type="bibr" rid="b28">Manning <italic>et al</italic>, 2002</xref>
###xml 1205 1210 1205 1210 <italic>et al</italic>
###xml 1197 1216 1197 1216 <xref ref-type="bibr" rid="b5">Brennan <italic>et al</italic>, 1999</xref>
The PDK1 PIF domain is required for the phosphorylation of multiple kinases, such as RSK and S6K1 (Collins et al, 2003). We examined the role of RSK in pre-T cell development using a recently described specific RSK inhibitor BI-D1870 (Sapkota et al, 2007). This inhibitor inhibits all four RSK isoforms, but not other related AGC kinases (Sapkota et al, 2007). Figure 5A shows that RSK inhibition does not prevent the DN to DP differentiation of WT pre-T cells, but does inhibit Notch-induced proliferative expansion of these pre-T cell subpopulations (Figure 5B). Inhibition of RSK with BI-D1870 thus allows cells to differentiate, but does not allow them to proliferate normally. We also considered the possible contribution of S6K1 to thymus development. S6K1 must be phosphorylated by PDK1 at its T loop site to become activated, but also has an additional requirement for PDK1 function as its activation is dependent on PKB, which regulates S6K1 via modulation of TSC-1/2 function and mTOR (mammalian target of rapamycin) (Inoki et al, 2002; Jaeschke et al, 2002; Manning et al, 2002). In this respect, in mature T cells, S6K1 couples PKB and mTOR to the control of T cell cycle progression (Brennan et al, 1999).
###end p 26
###begin p 27
###xml 94 101 94 101 <italic>in vivo</italic>
###xml 103 127 103 127 <xref ref-type="bibr" rid="b6">Chiang and Abraham, 2005</xref>
###xml 134 139 134 139 <italic>et al</italic>
###xml 129 145 129 145 <xref ref-type="bibr" rid="b19">Holz <italic>et al</italic>, 2005</xref>
###xml 148 163 148 163 <xref ref-type="fig" rid="f5">Figure 5C and D</xref>
###xml 246 254 246 254 <italic>in vitro</italic>
###xml 503 508 503 508 <italic>et al</italic>
###xml 493 514 493 514 <xref ref-type="bibr" rid="b40">Sarbassov <italic>et al</italic>, 2006</xref>
###xml 619 640 619 640 <xref ref-type="bibr" rid="b11">Dann and Thomas, 2006</xref>
###xml 952 978 952 978 <xref ref-type="bibr" rid="b12">Edinger and Thompson, 2002</xref>
###xml 1160 1169 1160 1169 <xref ref-type="fig" rid="f5">Figure 5E</xref>
Previous studies have shown that inhibition of mTOR with rapamycin reduces thymus cellularity in vivo (Chiang and Abraham, 2005; Holz et al, 2005). Figure 5C and D show that rapamycin blocks Notch-dependent proliferative expansion of pre-T cells in vitro, but not DN to DP differentiation. As rapamycin immediately inactivates S6K1, these results are consistent with a role for S6K1 in thymus development. However, important caveats are that rapamycin can disrupt sustained activation of PKB (Sarbassov et al, 2006). Moreover, mTOR is needed for PKB activation of S6K1, but can also regulate S6K1-independent pathways (Dann and Thomas, 2006). Accordingly, the ability of rapamycin to inhibit T cell proliferation may be explained by a requirement for mTOR signalling to mediate PKB function, rather than reflecting loss of S6K1 activity. In this context, in a pro-B cell line, PKB could induce expression of CD98 and CD71 via a mTOR-dependent pathway (Edinger and Thompson, 2002). To explore the mTOR requirement for nutrient receptor expression in pre-T cells, we examined the impact of rapamycin on CD98 and CD71 expression in the OP9 DL-1 system. The data (Figure 5E) show that the ability of Notch signals to sustain expression of CD98 and CD71 is partially sensitive to rapamycin inhibition. Hence, the expression of nutrient receptors in pre-T cells is regulated by PDK1- and mTOR-sensitive pathways.
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 129 162 129 162 <xref ref-type="bibr" rid="b42">Schmitt and Zuniga-Pflucker, 2005</xref>
###xml 164 176 164 176 <xref ref-type="bibr" rid="b16">Guidos, 2006</xref>
###xml 184 189 184 189 <italic>et al</italic>
###xml 178 195 178 195 <xref ref-type="bibr" rid="b50">Visan <italic>et al</italic>, 2006</xref>
###xml 453 454 450 451 <sc>L</sc>
The differentiation and proliferation of pre-T cells in the thymus is dependent on sustained Notch receptor/ligand interactions (Schmitt and Zuniga-Pflucker, 2005; Guidos, 2006; Visan et al, 2006). The present work shows that Notch-mediated trophic and proliferative responses are lost following deletion of PDK1. As T cell progenitors progress through beta-selection, there is induced cell surface expression of CD98, an essential subunit of mammalian L-type amino-acid transporters and CD71, the transferrin receptor. The expression of these nutrient receptors is induced by the pre-TCR in a Notch- and PDK1-dependent manner. Moreover, sustained Notch signalling is required to maintain CD71 and CD98 expression as pre-T cells progress through beta-selection. Strikingly, PDK1 deletion prevents expression of these key nutrient receptors and prevents Notch-induced growth responses. The observations that PDK1 regulates the expression of key amino-acid and iron transporters during thymocyte development and is required for Notch trophic responses offer an explanation as to why the loss of PDK1 has such a major impact on T cell development. The loss of nutrient receptor regulation in PDK1-null T cells will thus render the cells metabolically insufficient to support the demands made by the massive proliferative expansion occurring as thymocytes make the DN to DP transition.
###end p 29
###begin p 30
To investigate PDK1 substrates that control expression of CD98 and CD71, we looked at the expression of these nutrient receptors in pre-T cells expressing a PDK1 L155E allele that can activate PKB, but not AGC kinases that bind to PDK1 via its PIF domain. PDK1 L155E restores expression of CD71 and CD98 and also supports both the differentiation of pre-T cells to DP and mature SP cells. PKB thus has key functions regulating the expression of amino-acid transporters and transferrin receptors during thymocyte development. However, PDK1 L155E did not restore normal thymus cellularity. Hence, PKB activation is sufficient for thymocyte differentiation, but not sufficient for optimal proliferation. Accordingly, kinases that interact with PDK1 via its PIF domain are necessary for cell growth and proliferation of pre-T cells in the thymus. The role of PDK1 during thymocyte development is thus multifaceted and not simply a reflection of its role as an upstream activator of PKB.
###end p 30
###begin p 31
###xml 603 608 603 608 <italic>et al</italic>
###xml 597 614 597 614 <xref ref-type="bibr" rid="b36">Pende <italic>et al</italic>, 2004</xref>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
Serine/threonine kinases that interact with PDK1 via its PIF domain include RSK and S6K1. The present results identify RSK as an important signalling molecule for pre-T cell development, as inhibition of this kinase inhibited proliferative expansion of pre-T cells, but did not prevent their differentiation. The importance of the PDK1 PIF domain could thus be explained by its role in RSK regulation. However, there is still the question of the involvement of S6K1. It is difficult to assess a thymus autonomous role for S6Ks in mice doubly deficient for S6Ks, as these show perinatal lethality (Pende et al, 2004). Nevertheless, we tested the role of another S6K regulator mTOR in thymocyte growth and proliferation by examining the impact of rapamycin on Notch-induced thymocyte development. These experiments revealed that the inhibition of mTOR with rapamycin prevents optimal nutrient receptor expression and growth and proliferation of DN thymocytes, but permits their differentiation. Accordingly, there is a dual requirement for PDK1 and mTOR for cell growth and proliferation during thymocyte development.
###end p 31
###begin p 32
###xml 389 394 389 394 <italic>et al</italic>
###xml 382 400 382 400 <xref ref-type="bibr" rid="b3">Biondi <italic>et al</italic>, 2000</xref>
###xml 402 406 402 406 <xref ref-type="bibr" rid="b4">2001</xref>
###xml 415 420 415 420 <italic>et al</italic>
###xml 408 426 408 426 <xref ref-type="bibr" rid="b14">Frodin <italic>et al</italic>, 2000</xref>
###xml 428 432 428 432 <xref ref-type="bibr" rid="b13">2002</xref>
In summary, the present study shows that PDK1 is important during thymocyte development, because it regulates expression of key nutrient receptors on the surface of pre-T cells and mediates Notch-induced cell growth and proliferative responses. PDK1 was first identified as a key activator of PKB, but was also found to mediate activation of other AGC kinases such as RSK and S6K1 (Biondi et al, 2000, 2001; Frodin et al, 2000, 2002). A PDK1 L155E mutant, with a disrupted PIF pocket can support normal activation of PKB and restore nutrient receptor expression and DP and SP thymocyte differentiation in PDK1-null cells. However, PDK1 L155E cannot support normal thymocyte proliferation. The importance of PDK1 for beta-selection thus reflects the role of multiple AGC serine kinases in this process rather than just reflecting PKB regulation.
###end p 32
###begin title 33
Materials and methods
###end title 33
###begin title 34
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 34
###begin p 35
###xml 165 168 165 168 <sup>&#8722;/&#8722;</sup>
###xml 179 200 179 192 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 200 207 192 199 <italic>Lck-Cre</italic>
###xml 207 208 199 200 <sup>+</sup>
###xml 216 228 208 216 <sup>fl&#916;neo/&#8722;</sup>
###xml 228 235 216 223 <italic>Lck-Cre</italic>
###xml 235 236 223 224 <sup>+</sup>
###xml 286 291 274 279 <italic>et al</italic>
###xml 277 297 265 285 <xref ref-type="bibr" rid="b47">Takahama <italic>et al</italic>, 1998</xref>
###xml 306 311 294 299 <italic>et al</italic>
###xml 299 317 287 305 <xref ref-type="bibr" rid="b25">Lawlor <italic>et al</italic>, 2002</xref>
###xml 326 331 314 319 <italic>et al</italic>
###xml 319 337 307 325 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 346 349 334 337 <sup>&#8722;/&#8722;</sup>
###xml 460 465 448 453 <italic>et al</italic>
###xml 453 471 441 459 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
###xml 514 517 502 505 <sup>&#8722;/&#8722;</sup>
###xml 562 583 550 563 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
Mice (5- to 7-week-old) (backcrossed for at least seven generations to C57BL6) were maintained in SPF conditions under Home Office project license PPL60/3116. T-PDK1-/- mice (PDK1flDeltaneo/flDeltaneoLck-Cre+ or PDK1flDeltaneo/-Lck-Cre+ were generated as described previously (Takahama et al, 1998; Lawlor et al, 2002; Hinton et al, 2004). T-PDK1-/- mice have partial deletion of PDK1 in DN3 thymocytes and complete ablation of PDK1 in DN4 pre-T cells (Hinton et al, 2004). Control mice used for analyses of T-PDK1-/- mice were age-matched WT littermates or PDK1flDeltaneo/flDeltaneo where indicated.
###end p 35
###begin p 36
###xml 114 121 114 121 <sup>L155E/+</sup>
###xml 132 137 132 137 <italic>et al</italic>
###xml 124 143 124 143 <xref ref-type="bibr" rid="b9">Collins <italic>et al</italic>, 2003</xref>
###xml 167 188 167 180 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 286 302 278 290 <sup>L155E/fl&#916;neo</sup>
###xml 354 357 342 345 <italic>Cre</italic>
###xml 398 401 386 389 <italic>lck</italic>
###xml 398 401 386 389 <sup><italic>lck</italic></sup>
###xml 457 462 445 450 <italic>L155E</italic>
###xml 457 473 445 457 <sup><italic>L155E</italic>/fl&#916;neo</sup>
###xml 473 480 457 464 <italic>Lck-Cre</italic>
###xml 480 481 464 465 <sup>+</sup>
###xml 509 514 493 498 <italic>L155E</italic>
###xml 509 516 493 500 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 536 548 520 528 <sup>+/fl&#916;neo</sup>
###xml 548 555 528 535 <italic>Lck-Cre</italic>
###xml 555 556 535 536 <sup>+</sup>
###xml 578 581 558 561 <sup>+/&#8722;</sup>
###xml 659 671 639 647 <sup>+/fl&#916;neo</sup>
###xml 694 697 670 673 <italic>Cre</italic>
###xml 738 741 714 717 <italic>lck</italic>
###xml 738 741 714 717 <sup><italic>lck</italic></sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
Mice containing a knock-in mutation of PDK1, wherein leucine (L) at residue 155 was changed to glutamate (E) (PDK1L155E/+) (Collins et al, 2003) were crossed with PDK1flDeltaneo/flDeltaneo mice to generate mice expressing a single PDK1 L155E allele and a single PDK1 floxed allele (PDK1L155E/flDeltaneo). These were then backcrossed with mice expressing Cre recombinase under the control of the p56lck proximal promoter in T cell precursors to generate PDK1L155E/flDeltaneoLck-Cre+ mice (referred to as T-PDK1L155E/-). Control mice PDK1+/flDeltaneoLck-Cre+ (referred to as T-PDK+/-) were generated by crossing mice expressing a single PDK1 floxed allele (PDK1+/flDeltaneo) with mice expressing Cre recombinase under the control of the p56lck proximal promoter.
###end p 36
###begin title 37
PCR analysis
###end title 37
###begin p 38
###xml 83 90 83 90 <sup>L155E/&#8722;</sup>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Cre-mediated deletion of the floxed PDK1 allele from DP sorted thymocytes in T-PDK1L155E/- mice was confirmed by PCR using primers p99 (5'-ATC CCA AGT TAC TGA GTT GTG TTG GAA G) and p100 (5'-TGT GGA CAA ACA GCA ATG AAC ATA CAC GC). A PCR product of 200 bp was generated for WT and PIF alleles and a 250 bp band was generated when the flDeltaneo allele was present. A 200 bp product generated by PCR analysis using primers p80 (5'-CTA TGC TGT GTT ACT TCT TGG AGC ACA G) and p100 was indicative of deletion of exons 3 and 4 of PDK1.
###end p 38
###begin title 39
Flow cytometric analysis
###end title 39
###begin p 40
###xml 1063 1064 1052 1053 <sup>&#8722;</sup>
###xml 1161 1162 1142 1143 <sup>+</sup>
###xml 1166 1167 1147 1148 <sup>&#8722;</sup>
###xml 1176 1177 1157 1158 <sup>&#8722;</sup>
###xml 1181 1182 1162 1163 <sup>&#8722;</sup>
###xml 1251 1252 1232 1233 <sup>+</sup>
###xml 1261 1263 1239 1241 <sup>hi</sup>
###xml 1403 1408 1381 1386 <italic>et al</italic>
###xml 1392 1414 1370 1392 <xref ref-type="bibr" rid="b2">Besseyrias <italic>et al</italic>, 2007</xref>
###xml 1521 1528 1499 1506 <italic>ex vivo</italic>
###xml 1585 1590 1563 1568 <italic>et al</italic>
###xml 1578 1596 1556 1574 <xref ref-type="bibr" rid="b17">Hinton <italic>et al</italic>, 2004</xref>
Antibodies conjugated to fluorescein isothiocyanate, phycoerythrin, allophycocyanin and biotin were obtained from either Pharmingen (San Diego, CA, USA) or eBioscience (San Diego, CA, USA). TriColour-conjugated antibodies were obtained from Caltag (Burlingame, CA, USA). Cells were stained for surface expression of the following markers using the antibodies in parentheses: CD4 (RM4-5), CD8 (53-6.7), CD25 (7D4), CD44 (IM7), CD71 (C2), CD98 (RL388), Thy1.2 (53-2.1), TCR beta (H57-597), B220 (RA3-6B2) and TCR gamma/delta (GL3). Cells were stained with saturating concentrations of antibody in accordance with the manufacturer's instructions. Data were acquired on either a FACS Calibur (Becton Dickinson, Franklin Lakes, NJ, USA) or an LSR1 flow cytometer (Becton Dickinson) using CellQuest software and were analysed using either CellQuest (Becton Dickinson) or FlowJo (Treestar, San Carlos, CA, USA) software. Viable cells were gated according to their forward scatter and side scatter profiles. CD4 and CD8 DN subsets were gated by lineage exclusion (lineage-) of all CD4, CD8 DP and SP cells and TCR gamma/delta. DN3s and DN4s were further defined as CD25+CD44- and CD25-CD44- thymocytes, respectively. Mature SP thymocytes were defined as Thy-1+, TCRbetahi and positive for CD4 or CD8 expression. A DL4 IgG fusion protein was used to monitor Notch1 expression as described previously (Besseyrias et al, 2007). Cellular DNA content was measured by DAPI staining of saponin permeabilised cells. Phospho-S6 levels in ex vivo thymocytes was assessed as described previously (Hinton et al, 2004).
###end p 40
###begin title 41
OP9 cultures and assay
###end title 41
###begin p 42
###xml 58 63 58 63 <italic>et al</italic>
###xml 50 70 50 70 <xref ref-type="bibr" rid="b45">Schmitt <italic>et al</italic>, 2004b</xref>
###xml 335 336 330 331 <sup>+</sup>
###xml 340 341 335 336 <sup>&#8722;</sup>
###xml 356 357 351 352 <sup>&#8722;</sup>
###xml 361 362 356 357 <sup>&#8722;</sup>
###xml 539 540 534 535 <sup>+</sup>
###xml 548 549 543 544 <sup>+</sup>
OP9 bone marrow stromal cells expressing OP9-DL1 (Schmitt et al, 2004b) and control OP9 cells were a gift from Juan Carlos Zuniga-Pflucker (Toronto, Canada). OP9 cells were maintained in alphaMEM supplemented with 50 muM 2-mercaptoethanol, 100 U/ml penicillin, 1 mg/ml streptomycin and 20% heat-inactivated FBS. Sorted thymus DN3 (CD25+CD44-) and DN4 (CD25-CD44-) subsets were co-cultured on OP9 and OP9-DL1 monolayers for times indicated in Figure legends. DN3 and DN4 thymocytes were purified by first depleting thymic populations of CD4+ and CD8+ cells using an AutoMACs magnetic cell sorter (Miltenyi Biotech, Auburn, CA, USA) before sorting to a purity greater than 95%, using a FACS VantageSE cell sorter (Becton Dickinson). On day of harvest thymocytes were filtered through 50 mum filters to remove OP9 cells before developmental progression of T lineage cells was assessed.
###end p 42
###begin title 43
Western blot analysis
###end title 43
###begin p 44
###xml 327 328 323 324 <italic>g</italic>
Sorted DN3 and DN4 thymocytes were lysed on ice in NP-40 lysis buffer (50 mM Hepes (pH 7.4), 75 mM NaCl, 1% Nonidet P-40, 10 mM sodium fluoride, 10 mM iodoacetimide, 1 mM EDTA, 40 mM beta-glycerophosphate, protease inhibitors, 1 mM phenylmethylsulfonyl fluoride, 100 muM sodium orthovanadate). Lysates were centrifuged at 1600 g for 15 min at 4degreesC. Protein samples were separated by sodium dodecyl sulphate 4-12% polyacrylamide gel electrophoreisis, transferred to nitrocellulose membrane and detected by western blot analysis using standard techniques. Blots were probed with antibodies that recognise phosphorylated GSK3 alpha/beta on Ser21/9 (Cell Signaling Technologies, Danvers, MA, USA), total GSK3 alpha/beta (Upstate, Hampshire, UK), phosphorylated S6 ribosomal protein on Ser235/236 (Cell Signaling Technologies) and total S6 ribosomal protein (Cell Signaling Technologies).
###end p 44
###begin title 45
Supplementary Material
###end title 45
###begin p 46
Supplementary Figure 1
###end p 46
###begin p 47
Supplementary Figure 2
###end p 47
###begin p 48
Supplementary Figure 3
###end p 48
###begin p 49
Supplementary Figure 4
###end p 49
###begin p 50
Supplementary Figure Legends
###end p 50
###begin p 51
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
This work was supported by Wellcome Trust Programme Grant 60/3116 and Wellcome Trust Principal Research Fellowship (DAC). EM was supported by a Marie Heim-Vogtlin Fellowship PMP DB-115611/1. We thank Juan Carlos Zuniga-Pflucker for the generous gift of OP9 cell lines and for the seminal work that established this model; members of Biological Services Unit for mouse care; and our co-workers for critical reading of the manuscript.
###end p 51
###begin article-title 52
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Evaluation of approaches to generate PDK1 tissue specific knock-in mice. 
###end article-title 52
###begin article-title 53
Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. 
###end article-title 53
###begin article-title 54
Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA. 
###end article-title 54
###begin article-title 55
The PIF-binding pocket in PDK1 is essential for activation of S6 K and SGK, but not PKB. 
###end article-title 55
###begin article-title 56
p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes. 
###end article-title 56
###begin article-title 57
Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. 
###end article-title 57
###begin article-title 58
Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. 
###end article-title 58
###begin article-title 59
Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. 
###end article-title 59
###begin article-title 60
###xml 0 7 0 7 <italic>In vivo</italic>
In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. 
###end article-title 60
###begin article-title 61
###xml 0 7 0 7 <italic>In vivo</italic>
In vivo role of the phosphate groove of PDK1 defined by knock-in mutation. 
###end article-title 61
###begin article-title 62
###xml 42 47 <span type="species:ncbi:4932">yeast</span>
The amino acid sensitive TOR pathway from yeast to mammals. 
###end article-title 62
###begin article-title 63
Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. 
###end article-title 63
###begin article-title 64
A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. 
###end article-title 64
###begin article-title 65
A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. 
###end article-title 65
###begin article-title 66
###xml 49 54 <span type="species:ncbi:9606">human</span>
Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation. 
###end article-title 66
###begin article-title 67
Synergy between the pre-T cell receptor and Notch: cementing the alphabeta lineage choice. 
###end article-title 67
###begin article-title 68
The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development. 
###end article-title 68
###begin article-title 69
Antigen receptor regulation of phosphoinositide-dependent kinase 1 pathways during thymocyte development. 
###end article-title 69
###begin article-title 70
mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. 
###end article-title 70
###begin article-title 71
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. 
###end article-title 71
###begin article-title 72
Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. 
###end article-title 72
###begin article-title 73
###xml 104 111 104 111 <italic>in vivo</italic>
Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. 
###end article-title 73
###begin article-title 74
Phosphoinositide-dependent kinase l (PDK1) haplo-insufficiency inhibits production of alpha/beta (alpha/beta) but not gamma delta (gamma/delta) T lymphocytes. 
###end article-title 74
###begin article-title 75
TCR and Notch signaling in CD4 and CD8 T-cell development. 
###end article-title 75
###begin article-title 76
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Essential role of PDK1 in regulating cell size and development in mice. 
###end article-title 76
###begin article-title 77
###xml 60 65 <span type="species:ncbi:9606">human</span>
Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms. 
###end article-title 77
###begin article-title 78
Notch and the immune system. 
###end article-title 78
###begin article-title 79
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. 
###end article-title 79
###begin article-title 80
Unequal contribution of akt isoforms in the double-negative to double-positive thymocyte transition. 
###end article-title 80
###begin article-title 81
###xml 4 11 4 11 <italic>in vivo</italic>
The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knock-in mutation. 
###end article-title 81
###begin article-title 82
Regulation of thymocyte differentiation: pre-TCR signals and beta-selection. 
###end article-title 82
###begin article-title 83
Constitutively active protein kinase B enhances Lck and Erk activities and influences thymocyte selection and activation. 
###end article-title 83
###begin article-title 84
###xml 44 50 <span type="species:ncbi:10090">murine</span>
Structure, expression and regulation of the murine 4F2 heavy chain. 
###end article-title 84
###begin article-title 85
Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation. 
###end article-title 85
###begin article-title 86
Active protein kinase B regulates TCR responsiveness by modulating cytoplasmic-nuclear localization of NFAT and NF-kappa B proteins. 
###end article-title 86
###begin article-title 87
###xml 20 24 <span type="species:ncbi:10090">mice</span>
S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. 
###end article-title 87
###begin article-title 88
Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. 
###end article-title 88
###begin article-title 89
In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. 
###end article-title 89
###begin article-title 90
###xml 79 87 79 87 <italic>in vitro</italic>
###xml 92 99 92 99 <italic>in vivo</italic>
BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. 
###end article-title 90
###begin article-title 91
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. 
###end article-title 91
###begin article-title 92
###xml 84 92 84 92 <italic>in vitro</italic>
Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. 
###end article-title 92
###begin article-title 93
Thymus-derived signals regulate early T-cell development. 
###end article-title 93
###begin article-title 94
T-cell development, doing it in a dish. 
###end article-title 94
###begin article-title 95
Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. 
###end article-title 95
###begin article-title 96
###xml 112 120 112 120 <italic>in vitro</italic>
Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. 
###end article-title 96
###begin article-title 97
The role of receptor-mediated endocytosis in iron metabolism. 
###end article-title 97
###begin article-title 98
###xml 142 145 <span type="species:ncbi:9823">Pig</span>
Functional competence of T cells in the absence of glycosylphosphatidylinositol-anchored proteins caused by T cell-specific disruption of the Pig-a gene. 
###end article-title 98
###begin article-title 99
Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. 
###end article-title 99
###begin article-title 100
Structure and function of transferrin receptors and their relationship to cell growth. 
###end article-title 100
###begin article-title 101
Regulation of intrathymic T-cell development by Lunatic Fringe- Notch1 interactions. 
###end article-title 101
###begin article-title 102
Pleiotropic changes controlled by the pre-T-cell receptor. 
###end article-title 102
###begin article-title 103
Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes. 
###end article-title 103
###begin article-title 104
T-cell development made simple. 
###end article-title 104
###begin p 105
###xml 60 61 60 61 <bold>A</bold>
###xml 277 278 277 278 <bold>B</bold>
###xml 696 697 696 697 <bold>C</bold>
###xml 749 752 749 752 <sup>&#8722;/&#8722;</sup>
###xml 758 770 758 766 <sup>fl&#916;neo/&#8722;</sup>
###xml 770 777 766 773 <italic>Lck-Cre</italic>
###xml 777 778 773 774 <sup>+</sup>
###xml 901 902 897 898 <bold>D</bold>
###xml 944 947 940 943 <sup>&#8722;/&#8722;</sup>
###xml 1192 1193 1188 1189 <bold>E</bold>
###xml 1305 1312 1301 1308 <italic>ex vivo</italic>
###xml 1347 1350 1343 1346 <sup>+/+</sup>
###xml 1356 1377 1352 1365 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 1389 1392 1377 1380 <sup>&#8722;/&#8722;</sup>
###xml 1398 1419 1386 1399 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 1419 1426 1399 1406 <italic>Lck-Cre</italic>
###xml 1426 1427 1406 1407 <sup>+</sup>
###xml 1494 1495 1474 1475 <bold>F</bold>
###xml 1542 1549 1522 1529 <italic>ex vivo</italic>
###xml 1559 1562 1539 1542 <sup>&#8722;/&#8722;</sup>
###xml 1645 1648 1625 1628 <sup>&#8722;/&#8722;</sup>
###xml 1659 1662 1639 1642 <sup>+/+</sup>
###xml 1725 1726 1705 1706 <bold>G</bold>
###xml 1883 1890 1863 1870 <italic>ex vivo</italic>
###xml 1910 1913 1890 1893 <sup>+/+</sup>
###xml 1919 1940 1899 1912 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 1952 1955 1924 1927 <sup>&#8722;/&#8722;</sup>
###xml 1961 1982 1933 1946 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 1982 1989 1946 1953 <italic>Lck-Cre</italic>
###xml 1989 1990 1953 1954 <sup>+</sup>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 1429 1433 <span type="species:ncbi:10090">mice</span>
###xml 1992 1996 <span type="species:ncbi:10090">mice</span>
PDK1 is required for Notch-induced pre-T cell development. (A) Data show analysis of relative cell size (based on flow cytometric analysis of forward scatter) of G0/G1 thymocytes. WT DN3 thymocytes from were co-cultured for 2 days with OP9 or OP9-DL1 stromal cell monolayers. (B) Data show surface expression of CD4 and CD8 on thymocytes from WT mice before (input) and after culture on OP9 and OP9-DL1 for times indicated. DN thymocytes from WT mice were co-cultured for times indicated with OP9 or OP9-DL1. Numbers in brackets refer to fold proliferation. Numbers in quadrants indicate the percentage of each corresponding population. Data are representative of three independent experiments. (C) Data show analysis of relative cell size of T-PDK1-/- (PDK1flDeltaneo/-Lck-Cre+) DNs co-cultured for 2 days with OP9 or OP9-DL1 stromal cells. Data are representative of three independent experiments. (D) Data show CD4 and CD8 staining of T-PDK1-/- DNs following co-culture on OP9-DL1 for times indicated. Numbers in brackets refer to fold proliferation. Numbers in quadrants indicate the percentage of each corresponding population. Data are representative of three independent experiments. (E) The data shows analysis of relative cell size, based on flow cytometric analysis of forward scatter, of G0/G1 ex vivo DN4 thymocytes from control T-PDK1+/+ (PDK1flDeltaneo/flDeltaneo) and T-PDK1-/- (PDK1flDeltaneo/flDeltaneoLck-Cre+) mice. Data are representative of three independent experiments. (F) Data show DL4-IgG fusion protein staining of ex vivo of T-PDK1-/- and normal littermate control DN4s. Geometric mean fluorescent intensities; T-PDK1-/-=68, T-PDK1+/+=110. Data are representative of two independent experiments. (G) The data show analysis of relative cell size, based on flow cytometric analysis of forward scatter, of region A (F) gated DN4 thymocytes taken immediately ex vivo from control T-PDK1+/+ (PDK1flDeltaneo/flDeltaneo) and T-PDK1-/- (PDK1flDeltaneo/flDeltaneoLck-Cre+) mice.
###end p 105
###begin p 106
###xml 100 101 100 101 <bold>A</bold>
###xml 227 228 227 228 <bold>B</bold>
###xml 522 523 522 523 <bold>C</bold>
###xml 778 779 778 779 <bold>D</bold>
###xml 903 906 903 906 <sup>&#8722;/&#8722;</sup>
###xml 1029 1030 1029 1030 <bold>E</bold>
###xml 1110 1111 1110 1111 <sup>&#8722;</sup>
###xml 1115 1116 1115 1116 <sup>&#8722;</sup>
###xml 1147 1154 1147 1154 <italic>ex vivo</italic>
###xml 1166 1169 1166 1169 <sup>&#8722;/&#8722;</sup>
###xml 1175 1196 1175 1188 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 1196 1203 1188 1195 <italic>Lck-Cre</italic>
###xml 1203 1204 1195 1196 <sup>+</sup>
###xml 1212 1216 <span type="species:ncbi:10090">mice</span>
Nutrient receptor expression is regulated by Notch during thymocyte development and requires PDK1. (A) Data show CD98 and CD71 expression on WT DN3 and DN4 thymocytes. Data are representative of three independent experiments. (B) Data show CD98 and CD71 expression levels in sorted DN3 WT thymocytes co-cultured on OP9 and OP9-DL1 monolayers for times indicated. Analysis of relative cell size, based on flow cytometric analysis of forward scatter, is also shown. Data is representative of three independent experiments. (C) Data show expression of CD98 and CD71 and relative cell size based on flow cytometric analysis of forward scatter for sorted DN4 WT thymocytes co-cultured on OP9 and OP9-DL1 monolayers for 26 h. Data is representative of three independent experiments. (D) Data show expression of CD98 and CD71 and relative cell size based on flow cytometric analysis of forward scatter for RAG2-/- thymocytes co-cultured on OP9 and OP9-DL1 monolayers for 26 h. Data are representative of three independent experiments. (E) The data show flow cytometry for CD98 and CD71 surface expression on DN4 (CD25-CD44-) thymocytes taken immediately ex vivo from T-PDK1-/- (PDK1flDeltaneo/flDeltaneoLck-Cre+) or WT mice. Data is representative of two independent experiments.
###end p 106
###begin p 107
###xml 81 82 81 82 <bold>A</bold>
###xml 219 220 219 220 <sup>*</sup>
###xml 497 502 497 502 <italic>et al</italic>
###xml 489 508 489 508 <xref ref-type="bibr" rid="b9">Collins <italic>et al</italic>, 2003</xref>
###xml 512 513 512 513 <bold>B</bold>
###xml 594 597 594 597 <sup>+/&#8722;</sup>
###xml 603 615 603 611 <sup>+/fl&#916;neo</sup>
###xml 615 622 611 618 <italic>Lck-Cre</italic>
###xml 622 623 618 619 <sup>+</sup>
###xml 635 640 631 636 <italic>L155E</italic>
###xml 635 642 631 638 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 648 664 644 656 <sup>L155E/fl&#916;neo</sup>
###xml 664 671 656 663 <italic>Lck-Cre</italic>
###xml 671 672 663 664 <sup>+</sup>
###xml 691 692 683 684 <bold>C</bold>
###xml 738 741 730 733 <sup>&#8722;/&#8722;</sup>
###xml 747 768 739 752 <sup>fl&#916;neo/fl&#916;neo</sup>
###xml 768 775 752 759 <italic>Lck-Cre</italic>
###xml 775 776 759 760 <sup>+</sup>
###xml 785 788 769 772 <sup>+/&#8722;</sup>
###xml 799 804 783 788 <italic>L155E</italic>
###xml 799 806 783 790 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 870 871 854 855 <bold>D</bold>
###xml 933 936 917 920 <sup>&#8722;/&#8722;</sup>
###xml 944 947 928 931 <sup>+/&#8722;</sup>
###xml 958 963 942 947 <italic>L155E</italic>
###xml 958 965 942 949 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 970 971 954 955 <sup>+</sup>
###xml 1051 1052 1035 1036 <bold>E</bold>
###xml 1101 1104 1082 1085 <sup>+/&#8722;</sup>
###xml 1115 1120 1096 1101 <italic>L155E</italic>
###xml 1115 1122 1096 1103 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 1135 1136 1116 1117 <bold>F</bold>
###xml 1221 1224 1202 1205 <sup>+/&#8722;</sup>
###xml 1235 1240 1216 1221 <italic>L155E</italic>
###xml 1235 1242 1216 1223 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 1305 1312 1286 1293 <italic>ex vivo</italic>
###xml 1526 1527 1507 1508 <bold>G</bold>
###xml 1654 1659 1628 1633 <italic>L155E</italic>
###xml 1654 1661 1628 1635 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 1680 1683 1654 1657 <sup>&#8722;/&#8722;</sup>
PDK1 L155E restores nutrient receptor expression and thymocyte differentiation. (A) A schematic representation of PDK1 L155E. A leucine (L) to glutamate (E) mutation at residue 155 in the PIF domain of PDK1 (denoted by *) prevents docking of PDK1 at the H-motif of substrates S6K, SGK and RSK. This prevents their T loop phosphorylation by PDK1 and subsequent activation. Dotted lines represent these inactivated pathways. PDK1 L155E mutation is permissive for PKB activation (solid line)(Collins et al, 2003). (B) Data show CD98 (left panel) and CD71 (right panel) expression on control T-PDK1+/- (PDK1+/flDeltaneoLck-Cre+) and T-PDK1L155E/- (PDK1L155E/flDeltaneoLck-Cre+) DN4 thymocytes. (C) Data show CD44 and CD25 expression on T-PDK1-/- (PDK1flDeltaneo/flDeltaneoLck-Cre+), T-PDK1+/- and T-PDK1L155E/- DNs. Data are representative of four independent experiments. (D) Flow cytometric analysis of CD4 and CD8 expression on T-PDK1-/-, T-PDK1+/- and T-PDK1L155E/- Thy1+ thymocytes is shown. Data are representative of four independent experiments. (E) Data show TCRbeta staining of Thy1-gated T-PDK1+/- and T-PDK1L155E/- thymocytes (F) Data shows intracellular staining for phosphorylated S6 ribosomal protein in T-PDK1+/- and T-PDK1L155E/- DN4s. Data show phospho S6 staining in thymocytes immediately ex vivo (filled histogram) or treated with 20 nM rapamycin (open histogram) as an internal negative control to reduce S6 protein phosphorylation to basal levels. Data are representative of three independent experiments. (G) Data show western blot analysis of phosphoGSK3 alpha/beta Ser21/9 and S6 ribosomal protein Ser235/6 in wild type (WT), T-PDK1L155E/- (L155E) and T-PDK1-/- DN3 and DN4 thymocytes.
###end p 107
###begin p 108
###xml 49 50 49 50 <bold>A</bold>
###xml 68 71 68 71 <sup>+/&#8722;</sup>
###xml 77 89 77 85 <sup>+/fl&#916;neo</sup>
###xml 89 96 85 92 <italic>Lck-Cre</italic>
###xml 96 97 92 93 <sup>+</sup>
###xml 109 114 105 110 <italic>L155E</italic>
###xml 109 116 105 112 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 122 138 118 130 <sup>L155E/fl&#916;neo</sup>
###xml 138 145 130 137 <italic>Lck-Cre</italic>
###xml 145 146 137 138 <sup>+</sup>
###xml 206 209 198 201 <sup>+/&#8722;</sup>
###xml 211 212 203 204 <italic>n</italic>
###xml 226 231 218 223 <italic>L155E</italic>
###xml 226 233 218 225 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 235 236 227 228 <italic>n</italic>
###xml 271 274 263 266 <sup>+/&#8722;</sup>
###xml 276 277 268 269 <italic>n</italic>
###xml 291 296 283 288 <italic>L155E</italic>
###xml 291 298 283 290 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 300 301 292 293 <italic>n</italic>
###xml 336 339 328 331 <sup>+/&#8722;</sup>
###xml 341 342 333 334 <italic>n</italic>
###xml 356 361 348 353 <italic>L155E</italic>
###xml 356 363 348 355 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 365 366 357 358 <italic>n</italic>
###xml 377 378 369 370 <bold>B</bold>
###xml 431 434 416 419 <sup>+/&#8722;</sup>
###xml 445 450 430 435 <italic>L155E</italic>
###xml 445 452 430 437 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 460 461 445 446 <bold>C</bold>
###xml 563 566 548 551 <sup>+/&#8722;</sup>
###xml 568 569 553 554 <italic>n</italic>
###xml 583 588 568 573 <italic>L155E</italic>
###xml 583 590 568 575 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 592 593 577 578 <italic>n</italic>
###xml 617 619 602 604 <sup>**</sup>
###xml 619 620 604 605 <italic>P</italic>
###xml 653 654 638 639 <bold>D</bold>
###xml 760 763 745 748 <sup>+/&#8722;</sup>
###xml 774 779 759 764 <italic>L155E</italic>
###xml 774 781 759 766 <sup><italic>L155E</italic>/&#8722;</sup>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
PDK1 L155E does not restore thymus cellularity. (A) Data show T-PDK1+/- (PDK1+/flDeltaneoLck-Cre+) and T-PDK1L155E/- (PDK1L155E/flDeltaneoLck-Cre+) thymocyte subpopulation numbers. For DN thymocytes; T-PDK1+/- (n=4) and T-PDK1L155E/- (n=3) mice, for DP thymocytes; T-PDK1+/- (n=4) and T-PDK1L155E/- (n=8) mice, for SP thymocytes; T-PDK1+/- (n=4) and T-PDK1L155E/- (n=6) mice. (B) Data show numbers of alpha/beta T cells from T-PDK1+/- and T-PDK1L155E/- mice. (C) Data show the percentage of cells in the proliferative (S and G2) stages of the cell cycle in T-PDK1+/- (n=4) and T-PDK1L155E/- (n=4) DN3 and DN4 cells. (**P-value of significance 0.0074). (D) Data show analysis of relative cell size based on flow cytometric analysis of forward scatter for T-PDK1+/- and T-PDK1L155E/- DN3 and DN4 thymocytes. Data are representative of four independent experiments.
###end p 108
###begin p 109
###xml 91 92 91 92 <bold>A</bold>
###xml 337 338 336 337 <bold>B</bold>
###xml 481 482 480 481 <bold>C</bold>
###xml 716 717 715 716 <bold>D</bold>
###xml 935 936 934 935 <bold>E</bold>
Inhibition of either mTOR or RSK permits thymocyte differentiation but not proliferation. (A) The data show surface expression of CD4 and CD8 on DN WT thymocytes following 3 days co-culture with 5 ng/ml IL7 on OP9-DL1 monolayers in the presence or absence of 10 muM BI-D1870. The data are representative of two independent experiments. (B) Data show numbers of cells following 6 days co-culture of DN thymocytes on OP9-DL1 in the presence of BI-D1870 at concentrations indicated. (C) Data show the number of cells following 6 days co-culture of DN thymocytes co-cultured on OP9-DL1 monolayers with 5 ng/ml IL7 in the presence or absence of 20 nM rapamycin. Data are representative of three independent experiments. (D) Data show CD4 and CD8 expression on DN3 WT thymocytes following 6 days co-culture with 5 ng/ml IL7 on OP9-DL1 in the presence or absence of 20 nM rapamycin. Data are representative of three independent experiments. (E) Data show CD98 (left panel) and CD71 (right panel) surface expression on DN3 thymocytes, following 2 days co-culture with 20 nM rapamycin on OP9-DL1. Data are representative of three independent experiments.
###end p 109

